To our knowledge, this is the first study to elucidate the molecular mechanism by which OPG downregulation promotes CRC metastasis and to show that blockade of this pathway can be a favorable treatment strategy for CRC liver metastasis. Here, TNFRSF11B is linked to colorectal carcinoma.